Home›Legal›BPC-157 in Pennsylvania
BPC-157 in Pennsylvania: Legal Status & Provider Guide (2026)
Quick Answer
BPC-157 is a prescription substance in the United States. BPC-157 has no FDA-approved drug application. It is classified as a research peptide and cannot be compounded by 503A/503B pharmacies under current federal guidance. Clinical use in the U.S. occurs in a legal gray area — consult a healthcare attorney and licensed prescriber for current federal standing. In Pennsylvania, compounding is governed by the Pennsylvania State Board of Pharmacy (PSBP). Pennsylvania certified registered nurse practitioners (CRNPs) may prescribe compounded medications including peptides within a collaborative agreement. Physician assistants also require supervision agreements. Pennsylvania has moderately permissive telehealth rules, allowing prescribing after an appropriate telehealth evaluation. Pennsylvania prescribers must hold an active Pennsylvania license to prescribe to Pennsylvania residents.
Federal Legal Status
FDA Approval Status
Not FDA-approved as a drug. Not on any FDA bulk substances list for compounding.
Compounding Pharmacy Rules (Federal)
BPC-157 is not on the FDA 503A or 503B bulk substances lists, meaning licensed compounding pharmacies cannot legally compound it for individual patients under federal law. Its status as a bulk substance for compounding has been contested and remains legally uncertain. Some providers offer it under state-level regulatory frameworks, but federal compliance risk is elevated.
Also Known As
Body Protection Compound 157 · PL 14736
Primary Research Areas
- Tissue repair
- Gut health
- Tendon and ligament healing
- Angiogenesis
Pennsylvania Pharmacy Board & Compounding Rules
Compounding Overview
Pennsylvania's State Board of Pharmacy regulates compounding pharmacies with detailed sterile and non-sterile compounding standards. Pennsylvania has historically been home to several large-scale compounding operations. The state enforces USP 797 standards for sterile products and requires annual inspections for high-risk compounding. Pennsylvania is part of the northeastern corridor with significant demand from New York, New Jersey, and Delaware markets.
Notable Rules
- Pennsylvania requires pharmacies engaged in sterile compounding to have a separate license category.
- Annual inspections are required for pharmacies performing high-risk sterile compounding.
- Pennsylvania shares regulatory burden with the FDA for pharmacies also registered as 503B outsourcing facilities.
- Non-resident pharmacies shipping compounds into Pennsylvania must be registered with the PSBP.
- Pennsylvania and New York maintain some reciprocal licensing arrangements for pharmacy professionals.
Prescribing Requirements in Pennsylvania
Pennsylvania certified registered nurse practitioners (CRNPs) may prescribe compounded medications including peptides within a collaborative agreement. Physician assistants also require supervision agreements. Pennsylvania has moderately permissive telehealth rules, allowing prescribing after an appropriate telehealth evaluation. Pennsylvania prescribers must hold an active Pennsylvania license to prescribe to Pennsylvania residents.
About BPC-157
BPC-157 (Body Protection Compound 157) is a synthetic pentadecapeptide derived from a protein found in gastric juice. It has been studied in animal models for tissue repair, gut protection, and angiogenesis. No completed Phase III human trials exist as of 2026.
For more research information, mechanism of action, and provider availability, see the BPC-157 research profile on PeptideBase.
Frequently Asked Questions
- Is BPC-157 legal in the United States?
- BPC-157 exists in a legal gray area. It is not FDA-approved and is not on the 503A/503B bulk compounding lists. Research-use possession is generally not a federal crime, but commercial sale and compounding for human use carry significant legal risk.
- Can a doctor prescribe BPC-157?
- A licensed prescriber may write an order for BPC-157, but compounding pharmacies subject to FDA oversight cannot legally compound it. Some providers operate under state regulations or as research programs. Patients should consult both a physician and legal counsel.
BPC-157 Providers in Pennsylvania
No providers currently listed in Pennsylvania for BPC-157. Browse the full directory to find providers offering BPC-157.
Browse all BPC-157 providers →BPC-157 Legal Status in Other States
Pharmacy board rules and compounding regulations vary by state. Compare BPC-157 legal status across other major markets:
Content review: This educational overview is prepared by the PeptideBase editorial team and reviewed for factual accuracy. Reviewer byline coming soon (gated on 4.4). Last updated: .